Biological Information
Background Information:
Adapter protein which modulates coupling of a number of cell surface receptor kinases with specific signaling pathways. Binds to, and suppress signals from, activated receptors tyrosine kinases, including the insulin (INSR) and insulin-like growth factor (IGF1R) receptors. The inhibitory effect can be achieved by 2 mechanisms: interference with the signaling pathway and increased receptor degradation. Delays and reduces AKT1 phosphorylation in response to insulin stimulation. Blocks association between INSR and IRS1 and IRS2 and prevents insulin-stimulated IRS1 and IRS2 tyrosine phosphorylation. Recruits NEDD4 to IGF1R, leading to IGF1R ubiquitination, increased internalization and degradation by both the proteasomal and lysosomal pathways. May play a role in mediating insulin-stimulated ubiquitination of INSR, leading to proteasomal degradation. Negatively regulates Wnt signaling by interacting with LRP6 intracellular portion and interfering with the binding of AXIN1 to LRP6. Positive regulator of the KDR/VEGFR-2 signaling pathway. May inhibit NEDD4-mediated degradation of KDR/VEGFR-2. (https://www.uniprot.org/uniprotkb/Q13322/entry). SH2-domain binding assays were developed using Eurofins Discovery's proprietary KINOMEscan technology that utilizes DNA-tagged target proteins and a high sensitivity qPCR readout to enable highly sensitive (accurate ligand KDs measured down to low picomolar range) and quantitative competition binding assays.
Family:
Adaptor
Sub Family:
Signal Transducing Adaptor Protein (STAP)
Class:
SH2 domain containing
Protein Name:
GRB10
Uniprot Number:
Q13322
Gene Name:
GRB10
Gene ID:
2887
Accession Number:
NP_001357938.1
Organism:
Human
Construct Details:
Wild Type; Partial Length (Start/Stop:I536/R640); Mammalian Expression
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Testing Information
Test Sample Requirements:
50uL of a 1000X stock based on the top or final concentration being tested
Minimum Order Quantity:
24
Turnaround Time
Standard:
14 Business Days
Clinical Relevance
Therapeutic Area:
Oncology/ Inflammation/ Autoimmune
Additional Information
Brand:
SH2scan - DiscoverX
Testing Location:
USA - San Diego, CA